Problem: The 510(k) clearance of Companion Medical's InPen (a "smart" reusable insulin pen) is discussed in the lecture slides, and the clearance summary is located in the Supplemental Materials. From the point of view of patient safety, do you agree that risk assessment, human factors testing, and physician involvement were sufficient to preclude conducting a clinical study to include in the FDA submission? Need Assignment Help service?